Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.
Chang Andrew A, Li Haitao, Broadhead Geoffrey K, Hong Thomas, Schlub Timothy E, Wijeyakumar Wijeyanthy et al.
Intravitreal aflibercept effectively improved vision and reduced retinal fluid in patients with neovascular AMD previously resistant to other anti-VEGFs, offering a valuable treatment option.